Aurora Cannabis (ACB) Long-Term Deferred Tax (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Long-Term Deferred Tax of $1.8 million for Q1 2026, down 39.04% year-over-year from $2.9 million in Q1 2025, and up 1492.07% quarter-over-quarter from $112582.5 in Q4 2025.
Aurora Cannabis (ACB) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Long-Term Deferred Tax for 8 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Deferred Tax fell 39.04% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (down 39.04% YoY), while the FY2026 annual figure was $1.8 million, down 40.94% from the prior year.
- Long-Term Deferred Tax rose to $1.8 million in Q1 2026 per ACB's latest filing, from $112582.5 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $11.4 million in Q3 2023 and bottomed at $7843.4 in Q2 2022.
- Historically, Long-Term Deferred Tax has averaged $6.0 million across 5 years, with a median of $4.7 million in 2024.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax jumped 145062.13% — and 2025, when it sank 99.23%.
- Aurora Cannabis' Long-Term Deferred Tax stood at $9.9 million in 2022, then increased by 11.66% to $11.0 million in 2023, then slumped by 88.98% to $1.2 million in 2024, then sank by 90.75% to $112582.5 in 2025, then surged by 1492.07% to $1.8 million in 2026.
- Business Quant data shows ACB's Long-Term Deferred Tax at $1.8 million in Q1 2026, $112582.5 in Q4 2025, and $85742.9 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Aurora Cannabis | 233.45 Mn | 161.14 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 112,582.55 |
| Sep 30, 2025 | 85,742.93 |
| Jun 30, 2025 | 3.01 Mn |
| Mar 31, 2025 | 2.94 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 11.07 Mn |
| Jun 30, 2024 | 11.09 Mn |
| Mar 31, 2024 | 4.63 Mn |
| Dec 31, 2023 | 11.04 Mn |
| Sep 30, 2023 | 11.43 Mn |
| Jun 30, 2023 | 11.39 Mn |
| Mar 31, 2023 | 4.83 Mn |
| Dec 31, 2022 | 9.89 Mn |
| Sep 30, 2022 | 11.14 Mn |
| Jun 30, 2022 | 7,843.41 |
| Jun 30, 2021 | 661,397.58 |
| Mar 31, 2019 | 60,907.09 |
| Dec 31, 2018 | 93,944.85 |
| Jun 30, 2018 | 9.04 Mn |